EMA's Pharmacovigilance Activities to identify an alert signal
RESPONSIBLE PERSON FOR EUDRAVIGILANCE test - Soterius
EMA Approval Under Exceptional Circumstances - ProPharma
Ema Hilaj posted on LinkedIn
Information Day on Risk Management Planning and Post-Authorisation Studies
EMA richtet regulatorische Kontaktstelle ein | Dr. Haney Pharma GmbH
Register as EU QPPV or Responsible Person (RP) for EudraVigilance - Ottosen
Panacea - Working as a QPPV at Panacea
EMA publishes results of study on Brexit preparedness - Lexology
Questions and Answers to support the implementation of the
What's new in Pharmacovigilance?
Training Pharmacovigilance – PV PHARM
The key activities of a QPPV - ELC
What's new in Pharmacovigilance QPPV Update - Issue 1
EudraVigilance Registration Manual-V6_draft
EudraVigilance registration documents
Change of qualified person for pharmacovigilance and responsible person for EudraVigilance
EMA report echoes our calls on MAHs to stop signal detection activities in EudraVigilance - tepsivo.com
PVpharm on the EMA course: Mandatory use of ISO/ICH E2B(R3) Individual Case Safety Reporting in the EU – PV PHARM
EMA survey identifies gaps in pharma Brexit preparation
EudraVigilance Registration Manual-V2
Reporting requirements for marketing-authorisation holders | European Medicines Agency
RESPONSIBLE PERSON FOR EUDRAVIGILANCE test - Soterius
European Commission set to simplify EMA fees framework
EMA - Pubblicato l'aggiornamento del QPPV – Centro Regionale FarmacoVigilanza Sardegna
Regulatory contact point
